Lapatinib and Bevacizumab for Metastatic Breast Cancer

Clinical trial NCT00444535 · COMPLETED

Trial details

NCT number: NCT00444535
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2007-02-27
Primary completion: 2008-07-22
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.